Current research shows a possible association rather than confirmed causation, as patients taking semaglutide often have underlying risk factors including obesity and metabolic syndrome
What does this mean for patients & our practice GLP-1 treatment with semaglutide can offer cardiovascular protection beyond pure weight loss, a potentially valuable tool in treating overweight, together with established cardiovascular disease
You value consistency Made for customers who want an easy daily capsule routine that feels simple to maintain
This isnt just a product its a movement
The sustained tonic GH/IGF-1 elevation it produces rather than pulsatile bursts is both a research advantage (easier to measure steady-state changes in body composition) and a design consideration (it does not replicate physiological GH pulsatility, which may matter in neuroendocrine studies)
Focus on protein-rich foods (2535 grams per meal), whole grains, and non-starchy vegetables to maintain satiety without tirzepatide's appetite suppression
